Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmund Folefac

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Genitourinary Cancer|May 18, 2025
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate CancerBrendan Connell, Clara Hwang, Edmund Folefac, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer RiskDesmond Aroke, Edmund Folefac, Ni Shi, et al.
Journal of Geriatric Oncology|June 3, 2020
Multidisciplinary telemedicine and the importance of being seenSarah A Wall, Brittany Knauss, Amy Compston, et al.
Frontiers in Oncology|June 26, 2023
Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018)Shihua Wang, Ming Yin, Peng Wang, et al.
Neuro-Oncology Practice|March 5, 2021
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort studyIyad Alnahhas, Appaji Rayi, Joshua D Palmer, et al.
Clinical Genitourinary Cancer|July 1, 2022
Low-Dose Enzalutamide in Metastatic Prostate Cancer-Longevity Over Conventional Survival AnalysisVincent Vinh-Hung, Olena Gorobets, Gilles Natchagande, et al.
Cancer Medicine|November 8, 2019
Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancerMing Yin, Jing Zhao, Paul Monk, et al.
Clinical Genitourinary Cancer|May 17, 2020
Low-Dose Enzalutamide in Late-Elderly Patients (≥ 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate CancerVincent Vinh-Hung, Gilles Natchagande, Clarisse Joachim, et al.
Oncology|November 8, 2016
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two PatientsClaire F Verschraegen, Hibba Rehman, Bhargavi Pulluri, et al.
BMC Geriatrics|July 8, 2020
Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practiceCarolyn J Presley, Jessica L Krok-Schoen, Sarah A Wall, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Genitourinary Cancer|May 18, 2025
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate CancerBrendan Connell, Clara Hwang, Edmund Folefac, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2020
Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer RiskDesmond Aroke, Edmund Folefac, Ni Shi, et al.
Journal of Geriatric Oncology|June 3, 2020
Multidisciplinary telemedicine and the importance of being seenSarah A Wall, Brittany Knauss, Amy Compston, et al.
Frontiers in Oncology|June 26, 2023
Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018)Shihua Wang, Ming Yin, Peng Wang, et al.
Neuro-Oncology Practice|March 5, 2021
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort studyIyad Alnahhas, Appaji Rayi, Joshua D Palmer, et al.
Clinical Genitourinary Cancer|July 1, 2022
Low-Dose Enzalutamide in Metastatic Prostate Cancer-Longevity Over Conventional Survival AnalysisVincent Vinh-Hung, Olena Gorobets, Gilles Natchagande, et al.
Cancer Medicine|November 8, 2019
Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancerMing Yin, Jing Zhao, Paul Monk, et al.
Clinical Genitourinary Cancer|May 17, 2020
Low-Dose Enzalutamide in Late-Elderly Patients (≥ 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate CancerVincent Vinh-Hung, Gilles Natchagande, Clarisse Joachim, et al.
Oncology|November 8, 2016
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two PatientsClaire F Verschraegen, Hibba Rehman, Bhargavi Pulluri, et al.
BMC Geriatrics|July 8, 2020
Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practiceCarolyn J Presley, Jessica L Krok-Schoen, Sarah A Wall, et al.
Pageof 3